303
Views
58
CrossRef citations to date
0
Altmetric
Original Article

Oxidative Macromolecular Damage in Age-Related Macular Degeneration

, , , , , , & show all
Pages 1089-1093 | Received 01 Apr 2009, Accepted 20 Sep 2009, Published online: 03 Dec 2009

REFERENCES

  • Beatty S, Koh H, Phil M, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45:115–134.
  • Totan Y, Cekic O, Borazan M, et al. Plasma malondialdehyde and nitric oxide levels in age related macular degeneration. Br J Ophthalmol 2001;85:1426–1428.
  • Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidant, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90:7915–7922.
  • Harman D. Aging: Phenomena and theories. Ann NY Acad Sci 1998;854:1–7.
  • Voss P, Siems W. Clinical oxidation parameters of aging. Free Radic Res 2006;40:1339–1349.
  • Esterbaur H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hyroxynonenal. In: Packer L, Glazer AN (Eds.). Methods in Enzymology. New York: Academic Press, 1990; pp. 407–421.
  • Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464–478.
  • Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–1111.
  • Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112–119.
  • Wu LL, Chiou CC, Chang PY, et al. Urinary 8-OHdG: A marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004;339:1–9.
  • Mecocci P, Fano G, Fulle S, et al. Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle. Free Radic Biol Med 1999;26:303–308.
  • Pan HZ, Zhang H, Chang D, et al. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 2008;92:548–551.
  • Cutler RG. Human longevity and aging: Possible role of reactive oxygen species. Ann NY Acad Sci 1991;621:1–28.
  • Kono Y, Nakamura K, Kimura H, et al. Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure. Circ J 2006;70:1001–1005.
  • Ohia SE, Opere CA, Leday AM. Pharmacological consequences of oxidative stress in ocular tissues. Mutat Res 2005;579:22–36.
  • Liang FQ, Godley BF. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: A possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 2003;76:397–403.
  • Wang AL, Lukas TJ, Yuan M, et al. Increased mitochondrial DNA damage and down-regulation of DNA repair enzymes in aged rodent retinal pigment epithelium and choroid. Mol Vis 2008;14:644–651.
  • Ito T, Nakano M, Yamamoto Y, et al. Hemoglobin-induced lipid peroxidation in the retina: A possible mechanism for macular degeneration. Arch Biochem Biophys 1995;316:864–872.
  • Winkler BS, Boulton ME, Gottsch JD, et al. Oxidative damage and age-related macular degeneration. Mol Vis 1999;5:32.
  • De La Paz MA, Anderson RE. Regional and age-dependent variation in susceptibility of the human retina to lipid peroxidation. Invest Ophthalmol 1992;33:3497–3499.
  • Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab Rev 2000;32:307–326.
  • Dalle-Donne I, Giustarini D, Colombo R, et al. Protein carbonylation in human diseases. Trends Mol Med 2003;9:169–176.
  • Aslan M, Sabuncu T, Kocyigit A, et al. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2007;17:734–740.
  • Tarpey MM, Wink DA, Grisham MB. Methods for detection of reactive metabolites of oxygen and nitrogen: In vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 2004;286:R431–444.
  • Ethen CM, Reilly C, Feng X, et al. Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal. Invest Ophthalmol Vis Sci 2007;48:3469–3479.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.